Page 14 - Iontech News Today

Hong Kong said on Wednesday it had approved a version of the BioNTech Covid-19 vaccine for babies and children under five years old – part of broader measu..

A Pfizer executive admitted that she and other Pfizer officials did not know whether the company's COVID-19 vaccine would stop viral transmission before being publicly distributed last year.

Read more about Health News Roundup: Surge in Gambia child deaths linked cough syrup under control, president says; Canada authorizes Pfizer's Omicron retooled booster and more on Devdiscourse

Read more about Health News Roundup: Surge in Gambia child deaths linked cough syrup under control, president says; Becton recalls some sterilization containers due to quality breach and more on Devdiscourse

Read more about Health News Roundup: Surge in Gambia child deaths linked cough syrup under control, president says; White House says COVID booster campaign going well, should pick up and more on Devdiscourse

FDA vaccine chief Dr. Peter Marks said last week he expected a decision on boosters for that age group soon.

Pfizer-BioNTech seeks an FDA emergency use approval in the US for children aged 5-11. This booster dose is intended for the original Covid strain, Omicron, and BA.4 and BA.5 subvariants.

PARIS, Sept. 27 (Xinhua) -- France will launch a new vaccination campaign with Omicron-adapted bivalent COVID-19 vaccines next week amid another wave of infecti

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Monday that they have completed a submission to the U.S. Food and Drug Administration requesting Emergency Use Authorization

Updated boosters made by both Pfizer and rival Moderna rolled out earlier this month for everyone 12 and older.